N A Brophy
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
-
- Pharmacological Effects and Toxicity Studies
Papers in
- Oncology 9
- Drug Transport and Resistance Mechanisms 8
- Lung Cancer Research Studies 2
-
- Acute Myeloid Leukemia Research 1
- Co-authors
- Branimir I. ŠikićJoanne HalseyB L LumGeorge A. FisherMichael P. GoslandSonja KaubischNancy L. BartlettChristine Siegert
- Journals
- Journal of Clinical Oncology (5 papers)Cancer (2 papers)Anti-Cancer Drugs (2 papers)British Journal of Haematology (1 paper)The American Journal of Medicine (1 paper)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
N A Brophy
13 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 76
- Oncology 759
- Pediatrics, Perinatology and Child Health 246
- Hematology 107
- Biotechnology 78
- Pharmacology 78
Countries citing papers authored by N A Brophy
This map shows the geographic impact of N A Brophy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N A Brophy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N A Brophy more than expected).
Fields of papers citing papers by N A Brophy
This network shows the impact of papers produced by N A Brophy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N A Brophy. The network helps show where N A Brophy may publish in the future.
Co-authors
The 25 scholars most cited alongside N A Brophy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 51 | |
| 2 | 2000 | 35 | |
| 3 | 1994 | 9 | |
| 4 | 1994 | 161 | |
| 5 | 1994 | 6 | |
| 6 | 1994 | 3 | |
| 7 | 1993 | 116 | |
| 8 | 1992 | 36 | |
| 9 | 1992 | 192 | |
| 10 | 1992 | 249 | |
| 11 | 1990 | 81 | |
| 12 | 1988 | 73 | |
| 13 | Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. | 1987 | 167 |
About N A Brophy
N A Brophy is a scholar working on Oncology, Hematology, Epidemiology, Hepatology and Biotechnology, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Cancer therapeutics and mechanisms (5 papers), Neuroendocrine Tumor Research Advances (4 papers), Pharmacological Effects and Toxicity Studies (2 papers), Pediatric Hepatobiliary Diseases and Treatments (2 papers), Lung Cancer Treatments and Mutations (2 papers), Lung Cancer Research Studies (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Oncology (759 citations), Pediatrics, Perinatology and Child Health (246 citations), Hematology (107 citations), Biotechnology (78 citations) and Pharmacology (78 citations). N A Brophy has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Branimir I. Šikić, Joanne Halsey, B L Lum, George A. Fisher, Michael P. Gosland, Sonja Kaubisch, Nancy L. Bartlett, Christine Siegert, Thomas R. Gravelyn and Marc Peters‐Golden. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Anti-Cancer Drugs, British Journal of Haematology and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.